HemaChrome Enhances Mobile Health Technology for Blood Testing
- Admin
- Nov 18, 2024
- 2 min read
HemaChrome LLC, a digital mobile health startup, is making strides in blood testing technology by collaborating with Global Health Labs Inc. This partnership aims to enhance HemaChrome's innovative smartphone technology that measures blood hemoglobin levels noninvasively, making it accessible and affordable for patients worldwide.
Key Takeaways
HemaChrome's technology uses a smartphone camera to measure blood hemoglobin levels from a digital photo of the inner eyelid.
The collaboration with Global Health Labs focuses on improving the accuracy of this technology.
Anemia affects approximately 1.93 billion people globally, highlighting the need for accessible testing solutions.
Innovative Technology
HemaChrome's approach leverages machine learning and spectroscopy to transform standard smartphone cameras into hyperspectral imagers. This technology allows for the instant and noninvasive quantification of blood hemoglobin levels, which is crucial for diagnosing various health conditions, including anemia.
The company has developed a patent-pending method that accurately extracts true colors from digital photos, addressing challenges posed by different smartphone models and lighting conditions. This innovation is a significant factor in HemaChrome's collaboration with Global Health Labs, as it enhances the reliability of the measurements.
Collaboration With Global Health Labs
Global Health Labs, a nonprofit organization funded by Gates Ventures, is dedicated to improving health technology solutions for underserved communities. The partnership began in May 2024 and is expected to continue through 2025, focusing on advancing HemaChrome's algorithms and technology.
Huiri Kim, HemaChrome's CEO, expressed enthusiasm about the collaboration, emphasizing the shared mission to reduce health disparities globally. The partnership aims to develop technologies that make healthcare more accessible, particularly for vulnerable populations.
Addressing Global Health Issues
Anemia is a significant global health crisis, affecting nearly a quarter of the world's population. Traditional blood tests for hemoglobin levels are often expensive and require trained professionals, making them inaccessible in low-resource settings. HemaChrome's technology aims to bridge this gap by providing a cost-effective and user-friendly solution.
Key statistics about anemia include:
Affects 1.93 billion people worldwide.
Ranks as the third-leading cause of disabilities globally.
Often goes undiagnosed due to lack of affordable testing.
Future Prospects
With the support of Global Health Labs, HemaChrome aims to launch a minimally viable product by late 2025. The company is optimistic about the potential for ongoing collaboration, particularly in refining their color calibration technology, which could revolutionize digital healthcare.
Conclusion
HemaChrome's innovative approach to blood testing represents a significant advancement in mobile health technology. By making hemoglobin testing accessible and affordable, the company is poised to make a meaningful impact on global health, particularly in underserved communities. The collaboration with Global Health Labs underscores the importance of innovation in addressing health disparities and improving healthcare access worldwide.
Sources
HemaChrome collaborates with Global Health Labs to enhance its mobile health technology to test blood hemoglobin - News, Purdue University.
Comments